| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |